Items where Author is "Murray, Megan"

Up a level
Export as [feed] RSS
Group by: Item Type | Status | No Grouping
Jump to: Article
Number of items: 13.

Article

Mirastschijski, Ursula, Dinesh, Nilima, Baskaran, Sudarson, Wedekind, Dirk, Gavrilovic, Jelena, Murray, Megan Y, Bevan, Damon and Kelm, Sørge (2019) Novel specific human and mouse stromelysin-1 (MMP-3) and stromelysin-2 (MMP-10) antibodies for biochemical and immunohistochemical analyses. Wound Repair and Regeneration, 27 (4). pp. 309-323. ISSN 1067-1927

Murray, Megan Y., Zaitseva, Lyubov, Auger, Martin J., Craig, Jenny I.O., MacEwan, David, Rushworth, Stuart A. and Bowles, Kristian M. (2015) Ibrutinib inhibits BTK-driven NF-κB p65 activity to overcome bortezomib-resistance in multiple myeloma. Cell Cycle, 14 (14). pp. 2367-2375. ISSN 1538-4101

Rushworth, Stuart A., Pillinger, Genevra, Abdul-Aziz, Amina, Piddock, Rachel, Shafat, Manar S., Murray, Megan Y., Zaitseva, Lyubov, Lawes, Matthew J., MacEwan, David J. and Bowles, Kristian M. (2015) Activity of Bruton's tyrosine-kinase inhibitor ibrutinib in patients with CD117-positive acute myeloid leukaemia: a mechanistic study using patient-derived blast cells. The Lancet Haematology, 2 (5). e204-e211.

Zaitseva, Lyubov, Murray, Megan Y, Shafat, Manar S., Lawes, Matthew J, MacEwan, David J, Bowles, Kristian M and Rushworth, Stuart A (2014) Ibrutinib inhibits SDF1/CXCR4 mediated migration in AML. Oncotarget, 5 (20). pp. 9930-9938. ISSN 1949-2553

Murray, Megan, Auger, Martin and Bowles, Kristian (2014) Overcoming bortezomib resistance in multiple myeloma. Biochemical Society Transactions, 42 (4). pp. 804-808. ISSN 0300-5127

Rushworth, Stuart A, Murray, Megan Y, Zaitseva, Lyubov, Bowles, Kristian M and Macewan, David J (2014) Identification of Bruton's tyrosine kinase as a therapeutic target in acute myeloid leukemia. Blood, 123 (8). pp. 1229-1238. ISSN 0006-4971

Murray, Megan Y, Rushworth, Stuart A, Zaitseva, Lyubov, Bowles, Kristian M and Macewan, David J (2013) Attenuation of dexamethasone-induced cell death in multiple myeloma is mediated by miR-125b expression. Cell Cycle, 12 (13). pp. 2144-2153. ISSN 1551-4005

Murray, Megan, Birkland, Timothy, Howe, Jonathan, Rowan, Andrew D., Fidock, Mark, Parks, William and Gavrilovic, Jelena (2013) Macrophage migration and invasion is regulated by MMP10 expression. PLoS One, 8 (5). ISSN 1932-6203

Rushworth, S, Bowles, KM, Barrera Briceno, LN, Murray, MY, Zaitseva, L and Macewan, DJ (2013) BTK inhibitor ibrutinib is cytotoxic to myeloma and potently enhances bortezomib and lenalidomide activities through NF-κB. Cellular Signalling, 25 (1). pp. 106-112.

Shah, Niraj, Rushworth, Stuart, Murray, Megan, Bowles, Kristian and Macewan, David (2013) Understanding the role of NRF2-regulated miRNAs in human malignancies. Oncotarget, 4 (8). pp. 1130-1142. ISSN 1949-2553

Rushworth, SA, Zaitseva, L, Murray, MY, Shah, NM, Bowles, KM and Macewan, DJ (2012) The high Nrf2 expression in human acute myeloid leukemia is driven by NF-κB and underlies its chemo-resistance. Blood, 120 (26). pp. 5188-5198. ISSN 0006-4971

Rushworth, SA, Murray, MY, Barrera Briceno, L, Heasman, S-A, Zaitseva, L and Macewan, DJ (2012) Understanding the role of miRNA in regulating NF-kB in blood cancer. American Journal of Cancer Research, 2 (1). pp. 65-74. ISSN 2156-6976

Murray, MY, Rushworth, SA and Macewan, DJ (2011) Micro RNAs as a new therapeutic target towards leukaemia signalling. Cellular Signalling, 24 (2). pp. 363-368.

This list was generated on Wed Aug 17 10:24:19 2022 UTC.